Detalhe da pesquisa
1.
Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry.
Mult Scler
; 29(2): 221-235, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36433775
2.
Upadacitinib improves patient-reported outcomes vs placebo or adalimumab in patients with rheumatoid arthritis: results from SELECT-COMPARE.
Rheumatology (Oxford)
; 60(12): 5583-5594, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33590829
3.
Upadacitinib monotherapy improves patient-reported outcomes in rheumatoid arthritis: results from SELECT-EARLY and SELECT-MONOTHERAPY.
Rheumatology (Oxford)
; 60(7): 3209-3221, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33313898
4.
Risk of Ocular Complications in Patients with Noninfectious Intermediate Uveitis, Posterior Uveitis, or Panuveitis.
Ophthalmology
; 123(3): 655-62, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26712559
5.
Direct Costs in Patients with Celiac Disease in the USA: A Retrospective Claims Analysis.
Dig Dis Sci
; 61(10): 2823-2830, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27417565
6.
U.S. emergency departments visits resulting from poor medication adherence: 2005-07.
J Am Pharm Assoc (2003)
; 53(5): 513-9, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24030129
7.
Real-world treatment patterns and effectiveness of cladribine tablets in patients with relapsing forms of multiple sclerosis in the United States.
Mult Scler Relat Disord
; 79: 105052, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37832254
8.
A Real-World Effectiveness Study Using a Mobile Application to Evaluate Early Outcomes with Upadacitinib in Rheumatoid Arthritis.
Rheumatol Ther
; 10(6): 1519-1533, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37728861
9.
A plain language summary on the effectiveness of cladribine tablets compared with other oral treatments for multiple sclerosis: results from the MSBase registry.
Neurodegener Dis Manag
; 13(4): 215-221, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37287269
10.
National burden of pediatric hospitalizations for inflammatory bowel disease: results from the 2006 Kids' Inpatient Database.
J Pediatr Gastroenterol Nutr
; 54(4): 477-85, 2012 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-22027564
11.
Patient-reported outcomes of upadacitinib versus abatacept in patients with rheumatoid arthritis and an inadequate response to biologic disease-modifying antirheumatic drugs: 12- and 24-week results of a phase 3 trial.
Arthritis Res Ther
; 24(1): 155, 2022 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35751108
12.
The national burden of E-code-identified adverse drug events among hospitalized children using a national discharge database.
Pharmacoepidemiol Drug Saf
; 20(8): 866-78, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21574209
13.
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study.
Adv Ther
; 38(5): 2558-2570, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837497
14.
Economic Benefit from Improvements in Quality of Life with Upadacitinib: Comparisons with Tofacitinib and Methotrexate in Patients with Rheumatoid Arthritis.
Adv Ther
; 38(12): 5649-5661, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34636000
15.
Cost-utility analyses of targeted immunomodulators in rheumatoid arthritis: systematic review.
J Med Econ
; 23(6): 610-623, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31971039
16.
Economic burden of fatigue or morning stiffness among patients with rheumatoid arthritis: a retrospective analysis from real-world data.
Curr Med Res Opin
; 36(1): 161-168, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31433680
17.
Correction to: Upadacitinib improves patient-reported outcomes in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: results from SELECT-NEXT.
Arthritis Res Ther
; 22(1): 137, 2020 06 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32517782
18.
Comparative Efficacy of JAK Inhibitors for Moderate-To-Severe Rheumatoid Arthritis: A Network Meta-Analysis.
Adv Ther
; 37(5): 2356-2372, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32297280
19.
Development and content validity of new patient-reported outcome questionnaires to assess the signs and symptoms and impact of atopic dermatitis: the Atopic Dermatitis Symptom Scale (ADerm-SS) and the Atopic Dermatitis Impact Scale (ADerm-IS).
Curr Med Res Opin
; 35(7): 1139-1148, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30561230
20.
Effects of upadacitinib on patient-reported outcomes: results from SELECT-BEYOND, a phase 3 randomized trial in patients with rheumatoid arthritis and inadequate responses to biologic disease-modifying antirheumatic drugs.
Arthritis Res Ther
; 21(1): 263, 2019 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31791386